Holen Sie sich die Stockscreener-App
233.13
1.02%
-2.40
Vorhandelsmarkt:
230.99
-2.14
-0.92%
Schlusskurs vom Vortag:
$235.53
Offen:
$235.58
24-Stunden-Volumen:
1.23M
Relative Volume:
0.94
Marktkapitalisierung:
$32.51B
Einnahmen:
$1.96B
Nettoeinkommen (Verlust:
$-253.24M
KGV:
-122.62
EPS:
-1.9012
Netto-Cashflow:
$94.06M
1W Leistung:
-2.13%
1M Leistung:
+12.82%
6M Leistung:
+41.10%
1J Leistung:
+40.06%
1-Tages-Spanne:
$231.68
$239.22
1-Wochen-Bereich:
$231.68
$246.90
52-Wochen-Spanne:
$125.38
$246.90
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Vergleichen Sie NTRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
233.13 | 32.84B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera (NTRA) Unveils Promising Results from Phase III Breast Ca - GuruFocus
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post‑Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2‑ Breast Cancer - Yahoo Finance
Natera acquires Foresight Diagnostics for up to $450M - MedTech Dive
Preimplantation Genetics Diagnosis Market size to exceed - openPR.com
Natera director Chapman sells shares for $1.06 million - Investing.com
What's Driving the Market Sentiment Around Natera Inc? - Benzinga
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Makes New $1.24 Million Investment in Natera, Inc. $NTRA - MarketBeat
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting - marketscreener.com
Wilson Sonsini Advises Foresight Diagnostics on Acquisition by Natera - Wilson Sonsini
Natera's (NTRA) Buy Rating Reiterated at Canaccord Genuity Group - MarketBeat
Natera, Inc. Stock (NTRA) Opinions on Foresight Acquisition and Signatera Data - Quiver Quantitative
BTIG Research Boosts Natera (NASDAQ:NTRA) Price Target to $260.00 - MarketBeat
Natera stock rises after Canaccord reiterates Buy rating following Foresight acquisition - Investing.com UK
Guggenheim Capital LLC Sells 4,628 Shares of Natera, Inc. $NTRA - MarketBeat
Natera purchases Foresight Diagnostics - Medical Device Network
Natera Makes High-Conviction Moves to Seize the Lucrative Oncology Frontier; Will It Succeed? - Smartkarma
Federated Hermes Inc. Has $129.71 Million Position in Natera, Inc. $NTRA - MarketBeat
Jump Financial LLC Purchases 18,821 Shares of Natera, Inc. $NTRA - MarketBeat
Invesco Ltd. Sells 165,294 Shares of Natera, Inc. $NTRA - MarketBeat
Natera Acquires Foresight Diagnostics - Oncodaily
Natera acquires Foresight Diagnostics to expand cancer detection capabilities By Investing.com - Investing.com Nigeria
Should Natera’s (NTRA) New Share Offering and Signatera Lymphoma Data Require Action From Investors? - simplywall.st
Dir Chapman Files To Sell 4,366 Of Natera Inc [NTRA] - TradingView
Natera envisions cancer-testing future with $450M Foresight buy - BioWorld MedTech
Boulder diagnostics co. bought by Austin biotech giant in $450M deal - The Business Journals
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
Working capital per share of Natera, Inc. – DUS:45E - TradingView
Natera buys Foresight Diagnostics in cancer testing deal worth up to $450M - Fierce Biotech
Austin biotech giant Natera acquires Colorado diagnostics company - The Business Journals
Natera (NASDAQ:NTRA) Hits New 1-Year HighWhat's Next? - MarketBeat
Natera Buys Foresight To Boost Super-Early Cancer Detection Tech - Benzinga
ETFs Investing in Natera, Inc. Stocks - TradingView
Natera Acquires Foresight Diagnostics for $275 Million - TipRanks
Natera Completes Foresight Diagnostics Acquisition in All-Stock Deal - marketscreener.com
Natera acquires Foresight Diagnostics - marketscreener.com
Natera stock reaches all-time high of 241.36 USD By Investing.com - Investing.com Nigeria
Steven Leonard Chapman Sells 4,400 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera, Inc. Earnings and Revenue – GETTEX:45E - TradingView
Net income of Natera, Inc. – GETTEX:45E - TradingView
Natera (NTRA): Assessing Valuation After a Powerful Multi‑Month Share Price Rally - Yahoo Finance
Natera stock reaches all-time high of 241.36 USD - Investing.com
Natera Inc: President Moshkevich sells $714k in stock By Investing.com - Investing.com South Africa
New York State Common Retirement Fund Raises Holdings in Natera, Inc. $NTRA - MarketBeat
XTX Topco Ltd Sells 34,439 Shares of Natera, Inc. $NTRA - MarketBeat
A Look At The Intrinsic Value Of Natera, Inc. (NASDAQ:NTRA) - Yahoo Finance
Edgestream Partners L.P. Grows Stock Position in Natera, Inc. $NTRA - MarketBeat
Arrowstreet Capital Limited Partnership Raises Position in Natera, Inc. $NTRA - MarketBeat
Natera acquires Foresight Diagnostics for $275 million - MSN
Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus
Natera Inc: President Moshkevich sells $714k in stock - Investing.com
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):